These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22196307)

  • 1. Olanzapine-associated myoclonus.
    Rosen JB; Milstein MJ; Haut SR
    Epilepsy Res; 2012 Feb; 98(2-3):247-50. PubMed ID: 22196307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine-induced myoclonic status.
    Camacho A; García-Navarro M; Martínez B; Villarejo A; Pomares E
    Clin Neuropharmacol; 2005; 28(3):145-7. PubMed ID: 15965316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine for psychotic and behavioral disturbances in Alzheimer disease.
    Schatz RA
    Ann Pharmacother; 2003 Sep; 37(9):1321-4. PubMed ID: 12921516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine-related repetitive focal seizures with lingual dystonia.
    Anzellotti F; Capasso M; Frazzini V; Onofrj M
    Epileptic Disord; 2016 Mar; 18(1):83-6. PubMed ID: 26898965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics].
    Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ
    Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin rash occurring with olanzapine pamoate, but not with oral olanzapine, in a male with juvenile idiopathic arthritis.
    Solfanelli A; Curto M; Dimitri-Valente G; Kotzalidis GD; Gasperoni C; Sani G; Manfredi G; Rapinesi C; Comparelli A; Girardi P
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):232-4. PubMed ID: 23607414
    [No Abstract]   [Full Text] [Related]  

  • 7. Olanzapine and delirium: lesson from clinical practice.
    Singh D; Forlano R
    Aust N Z J Psychiatry; 2008 May; 42(5):433-4. PubMed ID: 18499932
    [No Abstract]   [Full Text] [Related]  

  • 8. Nocturnal myoclonus observed in a patient with neuroleptic-induced akathisia.
    Nishimatsu O; Horiguchi J; Inami Y; Innami T; Sasaki A; Kondo K
    Jpn J Psychiatry Neurol; 1992 Mar; 46(1):121-6. PubMed ID: 1353123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Edema related to treatment with olanzapine].
    Wustmann T; Fiedler T; Gutmann P
    Psychiatr Prax; 2009 Apr; 36(3):142-4. PubMed ID: 18504690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine-induced chylomicronemia presenting as acute pancreatitis.
    Rossor AM; Leech N; Neely RD
    J Clin Psychopharmacol; 2007 Aug; 27(4):395-6. PubMed ID: 17632226
    [No Abstract]   [Full Text] [Related]  

  • 11. Olanzapine-induced tardive dystonia: a case report.
    Gnanavel S; Thanapal S; Khandelwal SK; Sood M
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E24-5. PubMed ID: 24763779
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care.
    Petersen AB; Andersen SE; Christensen M; Larsen HL
    Clin Toxicol (Phila); 2014 Jan; 52(1):39-43. PubMed ID: 24313745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of diabetes mellitus occurring during treatment with olanzapine: report of six cases and clinical implications.
    Ashim S; Warrington S; Anderson IM
    J Psychopharmacol; 2004 Mar; 18(1):128-32. PubMed ID: 15107197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug overdose-induced myoclonus complicated by rhabdomyolysis: possible role and mechanism of muscle toxicity of risperidone.
    Hsu YC; Yeh YW
    J Clin Pharm Ther; 2014 Dec; 39(6):698-700. PubMed ID: 25203795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine treatment of eight adolescent patients with psychosis.
    Ercan ES; Kutlu A; Varan A; Cikoğlu S; Coşkunol H; Bayraktar E
    Hum Psychopharmacol; 2004 Jan; 19(1):53-6. PubMed ID: 14716713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does propofol induction in patients on olanzapine increase the susceptibility to dystonic reactions?
    Papaioannou A; Mathioudakis E; Nyktari V; Astyrakaki E; Sgourou K; Askitopoulou H
    Acta Anaesthesiol Scand; 2011 May; 55(5):631. PubMed ID: 21827446
    [No Abstract]   [Full Text] [Related]  

  • 18. Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine.
    Kang SG; Lee HJ; Kim L
    J Psychopharmacol; 2009 Jul; 23(5):597-601. PubMed ID: 18562412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine-induced agranulocytosis in an adolescent male with psychosis.
    Freedman JL; Ryan CA; Coffey BJ
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):185-9. PubMed ID: 21504357
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.
    De Deyn PP; Carrasco MM; Deberdt W; Jeandel C; Hay DP; Feldman PD; Young CA; Lehman DL; Breier A
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):115-26. PubMed ID: 14758577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.